{"id":8215,"date":"2025-04-15T12:11:07","date_gmt":"2025-04-15T04:11:07","guid":{"rendered":"https:\/\/regask.com\/?p=8215"},"modified":"2025-04-15T12:11:07","modified_gmt":"2025-04-15T04:11:07","slug":"regask-im-healthcare-brew-zu-chinesischen-zollen-und-dem-us-gesundheitswesen","status":"publish","type":"post","link":"https:\/\/regask.com\/de\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/","title":{"rendered":"RegASK in Healthcare Brew: Wie Z\u00f6lle auf China \u2026"},"content":{"rendered":"<p class=\"\" data-start=\"238\" data-end=\"530\">Wir sind stolz darauf, das zu teilen <strong data-start=\"264\" data-end=\"306\">RegASK wurde vorgestellt in <a href=\"https:\/\/www.healthcare-brew.com\/stories\/2025\/02\/25\/how-tariffs-on-china-could-impact-us-healthcare\">Gesundheitsbrauerei<\/a><\/strong>neuster Artikel, <em data-start=\"325\" data-end=\"377\">\u201eWie sich Z\u00f6lle auf China auf das US-Gesundheitswesen auswirken k\u00f6nnten.\u201c<\/em> Der Artikel untersucht, wie neue Z\u00f6lle auf chinesische pharmazeutische Inhaltsstoffe die Arzneimittelpreise in die H\u00f6he treiben, Innovationen einschr\u00e4nken und die \u00f6ffentlichen Gesundheitssysteme belasten k\u00f6nnten.<\/p>\n<p class=\"\" data-start=\"532\" data-end=\"924\">RegASK CEO <strong data-start=\"559\" data-end=\"580\">Caroline Schleicher<\/strong> erl\u00e4utert die m\u00f6glichen Folgewirkungen dieser Z\u00f6lle und warnt vor <strong data-start=\"652\" data-end=\"676\">erh\u00f6hte Medikamentenkosten<\/strong>, <strong data-start=\"678\" data-end=\"701\">potenzielle Engp\u00e4sse<\/strong>, Und <strong data-start=\"707\" data-end=\"733\">geringere F&amp;E-Investitionen<\/strong>Ihre Erkenntnisse unterstreichen, wie dringend es f\u00fcr Aufsichtsbeh\u00f6rden, Gesundheitsdienstleister und Pharmaunternehmen ist, globale politische Ver\u00e4nderungen zu \u00fcberwachen, die den Zugang zu wichtigen Medikamenten erheblich beeintr\u00e4chtigen k\u00f6nnen.<\/p>\n<p class=\"\" data-start=\"926\" data-end=\"1121\">\ud83d\udd17 Den ganzen Artikel k\u00f6nnt ihr hier lesen: <a class=\"\" href=\"https:\/\/www.healthcare-brew.com\/stories\/2025\/02\/25\/how-tariffs-on-china-could-impact-us-healthcare\" target=\"_new\" rel=\"noopener\" data-start=\"954\" data-end=\"1121\">Healthcare Brew \u2013 Wie sich Z\u00f6lle auf China auf das US-Gesundheitswesen auswirken k\u00f6nnten<\/a><\/p>\n<p data-start=\"926\" data-end=\"1121\">Weitere Einblicke in die Auswirkungen politischer Ver\u00e4nderungen wie Z\u00f6lle auf die Pharmaindustrie finden Sie unter <a href=\"https:\/\/regask.com\/de\/regask-in-bloomberg-trump-droht-mit-zollen-gegen-pharmakonzern\/\"><strong data-start=\"1057\" data-end=\"1090\">RegASK-Beitrag in Bloomberg.<\/strong><\/a><\/p>\n<p data-start=\"921\" data-end=\"1114\">Bei RegASK haben wir uns der Bereitstellung pr\u00e4ziser und umsetzbarer Informationen verschrieben, die Regulierungsteams dabei helfen, sich in der sich st\u00e4ndig weiterentwickelnden Compliance-Landschaft von heute sicher zurechtzufinden.<\/p>","protected":false},"excerpt":{"rendered":"<p>Wir freuen uns, Ihnen mitteilen zu k\u00f6nnen, dass RegASK im neuesten Artikel von Healthcare Brew mit dem Titel \u201cWie sich Z\u00f6lle auf China auf das US-amerikanische Gesundheitswesen auswirken k\u00f6nnten\u201d erw\u00e4hnt wird. Der Artikel untersucht, wie neue Z\u00f6lle auf chinesische pharmazeutische Wirkstoffe die Arzneimittelpreise in die H\u00f6he treiben, Innovationen hemmen und die \u00f6ffentlichen Gesundheitssysteme belasten k\u00f6nnten. Caroline Shleifer, CEO von RegASK, erl\u00e4utert die potenziellen Folgewirkungen dieser Z\u00f6lle.<\/p>","protected":false},"author":22,"featured_media":8216,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[528],"tags":[],"class_list":["post-8215","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.4 (Yoast SEO v28.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>RegASK in Healthcare Brew: Impact of China Tariffs on US Pharma<\/title>\n<meta name=\"description\" content=\"RegASK CEO shares expert insights in Healthcare Brew on how China tariffs could disrupt US healthcare access and innovation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/de\/regask-im-healthcare-brew-zu-chinesischen-zollen-und-dem-us-gesundheitswesen\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RegASK featured in Healthcare Brew: How tariffs on China could impact US healthcare\" \/>\n<meta property=\"og:description\" content=\"RegASK CEO shares expert insights in Healthcare Brew on how China tariffs could disrupt US healthcare access and innovation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/de\/regask-im-healthcare-brew-zu-chinesischen-zollen-und-dem-us-gesundheitswesen\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-15T04:11:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1201\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Divvya Behal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Divvya Behal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\"},\"author\":{\"name\":\"Divvya Behal\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\"},\"headline\":\"RegASK featured in Healthcare Brew: How tariffs on Chin&hellip;\",\"datePublished\":\"2025-04-15T04:11:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\"},\"wordCount\":170,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-healthcare-brew.jpg\",\"articleSection\":[\"Company News\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\",\"name\":\"RegASK in Healthcare Brew: Impact of China Tariffs on US Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-healthcare-brew.jpg\",\"datePublished\":\"2025-04-15T04:11:07+00:00\",\"description\":\"RegASK CEO shares expert insights in Healthcare Brew on how China tariffs could disrupt US healthcare access and innovation.\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-healthcare-brew.jpg\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-healthcare-brew.jpg\",\"width\":1201,\"height\":900,\"caption\":\"Regask Featured Healthcare Brew\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\",\"name\":\"Divvya Behal\",\"sameAs\":[\"https:\\\/\\\/regask.com\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"RegASK im Healthcare Brew: Auswirkungen der chinesischen Z\u00f6lle auf die US-Pharmaindustrie","description":"Der CEO von RegASK gibt in Healthcare Brew Experteneinblicke dar\u00fcber, wie die chinesischen Z\u00f6lle den Zugang zum US-Gesundheitswesen und Innovationen beeintr\u00e4chtigen k\u00f6nnten.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/de\/regask-im-healthcare-brew-zu-chinesischen-zollen-und-dem-us-gesundheitswesen\/","og_locale":"de_DE","og_type":"article","og_title":"RegASK featured in Healthcare Brew: How tariffs on China could impact US healthcare","og_description":"RegASK CEO shares expert insights in Healthcare Brew on how China tariffs could disrupt US healthcare access and innovation.","og_url":"https:\/\/regask.com\/de\/regask-im-healthcare-brew-zu-chinesischen-zollen-und-dem-us-gesundheitswesen\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2025-04-15T04:11:07+00:00","og_image":[{"width":1201,"height":900,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","type":"image\/jpeg"}],"author":"Divvya Behal","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Divvya Behal","Est. reading time":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#article","isPartOf":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/"},"author":{"name":"Divvya Behal","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0"},"headline":"RegASK featured in Healthcare Brew: How tariffs on Chin&hellip;","datePublished":"2025-04-15T04:11:07+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/"},"wordCount":170,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","articleSection":["Company News"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/","url":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/","name":"RegASK im Healthcare Brew: Auswirkungen der chinesischen Z\u00f6lle auf die US-Pharmaindustrie","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","datePublished":"2025-04-15T04:11:07+00:00","description":"Der CEO von RegASK gibt in Healthcare Brew Experteneinblicke dar\u00fcber, wie die chinesischen Z\u00f6lle den Zugang zum US-Gesundheitswesen und Innovationen beeintr\u00e4chtigen k\u00f6nnten.","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","width":1201,"height":900,"caption":"Regask Featured Healthcare Brew"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Das regulatorische KI-Betriebssystem f\u00fcr leistungsstarke Teams","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Agentic AI ist eine Plattform f\u00fcr regulatorische Analysen und Workflow-Orchestrierung in den Bereichen Life Sciences und Konsumg\u00fcter. RegASK kombiniert vertikale LLMs, eine Multiagenten-KI-Architektur und eine globale Community von \u00fcber 1.800 Fachexperten, um regulatorische Zukunftsprognosen, Wirkungsanalysen, die Automatisierung von Compliance-Workflows und auditfertige Ergebnisse in \u00fcber 160 L\u00e4ndern bereitzustellen.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0","name":"Divvya Behal","sameAs":["https:\/\/regask.com"]}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/8215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/comments?post=8215"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/posts\/8215\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media\/8216"}],"wp:attachment":[{"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/media?parent=8215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/categories?post=8215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/de\/wp-json\/wp\/v2\/tags?post=8215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}